Chikungunya

Clinics in Laboratory Medicine

Volumn 30, Issue 1, 2010, Pages 209-219

  Powers, Ann M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Alphavirus; Chikungunya virus; Mosquito borne arbovirus

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; CHIKUNGUNYA VACCINE; CHLOROQUINE; CORTICOSTEROID; INTERFERON; POLYSACCHARIDE SULFATE; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTHRALGIA; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FLUID THERAPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REINFECTION; REST; REVIEW; SERODIAGNOSIS; TREATMENT OUTCOME; VACCINATION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ALPHAVIRUS INFECTIONS; CHIKUNGUNYA VIRUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; RECURRENCE;

EID: 77953336251     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.10.003     Document Type: Review

References (65)

1. Weaver S.C., Frey T.K., Huang H.V., et al. Togaviridae. Virus taxonomy: eighth report of the international committee on taxonomy of viruses 2005, 999-1008. Elsevier Academic Press, Amsterdam. C.M. Fauquet, M.A. Mayo, J. Maniloff (Eds.).
2. Strauss E.G., Strauss J.H. Structure and replication of the alphavirus genome. The Togaviruses and Flaviviruses 1986, 35-90. Plenum Press, New York. S. Schlesinger, M. Schlesinger (Eds.).
3. Robinson M.C. An epidemic of virus disease in Southern province, tanganyika territory, in 1952-53. I. clinical features. Trans R Soc Trop Med Hyg 1955, 49(1):28-32.
4. Ross R.W. The Newala epidemic.III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg 1956, 54:177-191.
5. Lumsden W.H., Robinson M.C. Investigations on an epidemic of dengue-like disease at Newala, Tanganyika Territory Part I - clinical picture, epidemiology, and entomology 1953, Virus Research Institute, Entebbe.
6. Nimmannitya S., Halstead S.B., Cohen S.N., et al. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969, 18(6):954-971.
7. Padbidri V.S., Gnaneswar T.T. Epidemiological investigations of chikungunya epidemic at Barsi, Maharashtra state, India. J Hyg Epidemiol Microbiol Immunol 1979, 23(4):445-451.
8. Jupp P.G., McIntosh B.M. Chikungunya virus disease. The arbovirus: epidemiology and ecology 1988, vol. II:137-157. CRC Press, Boca Raton, Florida. T.P. Monath (Ed.).
9. Powers A.M., Logue C.H. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007, 88(Pt 9):2363-2377.
10. Kariuki Njenga M., Nderitu L., Ledermann J.P., et al. Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J Gen Virol 2008, 89(Pt 11):2754-2760.
11. Ravi V. Re-emergence of Chikungunya virus in India. Indian J Med Microbiol 2006, 24(2):83-84.
12. Lanciotti R.S., Kosoy O.L., Laven J.J., et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007, 13(5):764-767.
13. Borgherini G., Poubeau P., Staikowsky F., et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007, 44(11):1401-1407.
14. Sergon K., Njuguna C., Kalani R., et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 2008, 78(2):333-337.
15. Gopalan S.S., Das A. Household economic impact of an emerging disease in terms of catastrophic out-of-pocket health care expenditure and loss of productivity: investigation of an outbreak of Chikungunya in Orissa, India. J Vector Borne Dis 2009, 46(1):57-64.
16. Seyler T., Hutin Y., Ramanchandran V., et al. Estimating the burden of disease and the economic cost attributable to Chikungunya, Andhra Pradesh, India, 2005-2006. Trans R Soc Trop Med Hyg 2010, 104(2):133-138.
17. Sergon K., Yahaya A.A., Brown J., et al. Seroprevalence of Chikungunya Virus Infection on Grande Comore Island, Union of the Comoros, 2005. Am J Trop Med Hyg 2007, 76(6):1189-1193.
18. Staples J.E., Breiman R.F., Powers A.M. Chikungunya Fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009, 49(6):942-948.
19. Angelini R., Finarelli A.C., Angelini P., et al. An outbreak of Chikungunya fever in the province of Ravenna, Italy. Euro Surveill 2007, 12(9). E070906 070901.
20. Schuffenecker I., Iteman I., Michault A., et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006, 3(7):e263.
21. Cherian S.S., Walimbe A.M., Jadhav S.M., et al. Evolutionary rates and timescale comparison of Chikungunya viruses inferred from the whole genome/E1 gene with special reference to the 2005-07 outbreak in the Indian subcontinent. Infect Genet Evol 2009, 9(1):16-23.
22. Powers A.M., Brault A.C., Tesh R.B., et al. Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 2000, 81(Pt 2):471-479.
23. Robinson M.C. An epidemic of a dengue-like fever in the southern province of Tanganyika. Cent Afr J Med 1956, 2(11):394-396.
24. Queyriaux B., Simon F., Grandadam M., et al. Clinical burden of Chikungunya virus infection. Lancet Infect Dis 2008, 8(1):2-3.
25. Sissoko D., Moendandze A., Malvy D., et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One 2008, 3(8):e3066.
26. Inamadar A.C., Palit A., Sampagavi V.V., et al. Cutaneous manifestations of Chikungunya fever: observations made during a recent outbreak in south India. Int J Dermatol 2008, 47(2):154-159.
27. Bandyopadhyay D., Ghosh S.K. Mucocutaneous features of Chikungunya fever: a study from an outbreak in West Bengal, India. Int J Dermatol 2008, 47(11):1148-1152.
28. Robin S., Ramful D., Zettor J., et al. Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr 2009, 169:67-72.
29. Wielanek A.C., Monredon J.D., Amrani M.E., et al. Guillan-Barré syndrome complicating a Chikungunya virus infection. Neurology 2007, 69(22):2105-2107.
30. Rampal S.M., Meena H. Neurological complications in Chikungunya fever. J Assoc Physicians India 2007, 55:765-769.
31. Singh S.S., Manimunda S.P., Sugunan A.P., et al. Four cases of acute flaccid paralysis associated with Chikungunya virus infection. Epidemiol Infect 2008, 136(9):1277-1280.
32. Chandak N.H., Kashyap R.S., Kabra D., et al. Neurological complications of Chikungunya virus infection. Neurol India 2009, 57(2):177-180.
33. Tandale B.V., Sathe P.S., Arankalle V.A., et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol 2009, 46(2):145-149.
34. Economopoulou A., Dominguez M., Helynck B., et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol Infect 2009, 137(4):534-541.
35. Fraser J.R., Becker G.J. Mononuclear cell types in chronic synovial effusions of Ross River virus disease. Aust N Z J Med 1984, 14(4):505-506.
36. Linn M.L., Mateo L., Gardner J., et al. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol 1998, 72(6):5146-5153.
37. Morrison T.E., Simmons J.D., Heise M.T. Complement receptor 3 promotes severe ross river virus-induced disease. J Virol 2008, 82(22):11263-11272.
38. Lidbury B.A., Simeonovic C., Maxwell G.E., et al. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000, 181(1):27-34.
39. Mahalingam S., Friedland J.S., Heise M.T., et al. Chemokines and viruses: friends or foes?. Trends Microbiol 2003, 11(8):383-391.
40. Mateo L., La Linn M., McColl S.R., et al. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology 2000, 43(1):55-60.
41. Brighton S.W., Prozesky O.W., de la Harpe A.L. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 1983, 63(9):313-315.
42. Panning M., Grywna K., van Esbroeck M., et al. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis 2008, 14(3):416-422.
43. Blackburn N.K., Besselaar T.G., Gibson G. Antigenic relationship between Chikungunya virus strains and o'nyong nyong virus using monoclonal antibodies. Res Virol 1995, 146(1):69-73.
44. Chanas A.C., Johnson B.K., Simpson D.I. Antigenic relationships of alphaviruses by a simple micro-culture cross-neutralization method. J Gen Virol 1976, 32(2):295-300.
45. Chanas A.C., Johnson B.K., Simpson D.I. Characterization of two Chikungunya virus variants. Acta Virol 1979, 23(2):128-136.
46. Karabatsos N. Antigenic relationships of group A arboviruses by plaque reduction neutralization testing. Am J Trop Med Hyg 1975, 24(3):527-532.
47. Williams M.C., Woodall J.P. O'nyong-nyong fever: an epidemic virus disease in East Africa. II. Isolation and some properties of the virus. Trans R Soc Trop Med Hyg 1961, 55:135-141.
48. Colin de Verdiere N., Molina J.M. Rheumatic manifestations caused by tropical viruses. Joint Bone Spine 2007, 74(5):410-413.
49. Kiwanuka N., Sanders E.J., Rwaguma E.B., et al. O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes. Clin Infect Dis 1999, 29(5):1243-1250.
50. Deller J.J., Russell P.K. Chikungunya disease. Am J Trop Med Hyg 1968, 17(1):107-111.
51. Jadhav M., Namboodripad M., Carman R.H., et al. Chikungunya disease in infants and children in Vellore: a report of clinical and haematological features of virologically proved cases. Indian J Med Res 1965, 53(8):764-776.
52. Tesh R.B. Arthritides caused by mosquito-borne viruses. Annu Rev Med 1982, 33:31-40.
53. Shore H. O'nyong-nyong fever: an epidemic virus disease in East Africa. III. Some clinical and epidemiological observations in the Northern Province of Uganda. Trans R Soc Trop Med Hyg 1961, 55:361.
54. Carey D.E., Myers R.M., DeRanitz C.M., et al. The 1964 Chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans R Soc Trop Med Hyg 1969, 63(4):434-445.
55. Halstead S.B., Nimmannitya S., Margiotta M.R. Dengue and Chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. Am J Trop Med Hyg 1969, 18(6):972-983.
56. Kularatne S.A., Gihan M.C., Weerasinghe S.C., et al. Concurrent outbreaks of Chikungunya and Dengue fever in Kandy, Sri Lanka, 2006-07: a comparative analysis of clinical and laboratory features. Postgrad Med J 2009, 85(1005):342-346.
57. Bouquillard E., Combe B. Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis 2009, 68(9):1505-1506.
58. Brighton S.W. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S Afr Med J 1984, 66(6):217-218.
59. Briolant S., Garin D., Scaramozzino N., et al. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 2004, 61(2):111-117.
60. de Lamballerie X., Ninove L., Charrel R.N. Antiviral treatment of Chikungunya virus infection. Infect Disord Drug Targets 2009, 9(2):101-104.
61. Borgherini G., Poubeau P., Jossaume A., et al. Persistent arthralgia associated with Chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 2008, 47(4):469-475.
62. Sissoko D., Malvy D., Ezzedine K., et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 2009, 3(3):e389.
63. Sudarsanareddy L., Sarojamma V., Ramakrishna V. Genetic predisposition to Chikungunya-a blood group study in Chikungunya affected families. J Virol 2009, 6:77.
64. Fulsundar S.R., Roy S., Manimunda S.P., et al. Investigations on possible role of MIF gene polymorphism in progression of Chikungunya infection into cases of acute flaccid paralysis and chronic arthropathy. J Genet 2009, 88(1):123-125.
65. Edelman R., Tacket C.O., Wasserman S.S., et al. Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000, 62(6):681-685.